Manufacturers now sell directly to patients through platforms like Eli Lilly's LillyDirect and Novo Nordisk's NovoCare, oral GLP-1 options have entered the market, and cash-pay prices have come down significantly from the $1,000-plus list prices of a few years ago
Semaglutide is a GLP1 receptor agonist
The brand name Zepbound (tirzepatide) is now much affordable than compounded Tirzepatide ( at $299/month on the lowest dose of 2.5mg /week and $449/month on the highest doses of 7.5mg and above ), so we recommend our patients to go that route
This, in turn, is increasing their production rates, where the growing government health campaigns are also increasing their use and awareness as well
They boost insulin release, slow down gastric emptying, and make you feel full